These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 33791873)

  • 1. Evidence for human diabetic cardiomyopathy.
    Marfella R; Sardu C; Mansueto G; Napoli C; Paolisso G
    Acta Diabetol; 2021 Aug; 58(8):983-988. PubMed ID: 33791873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial Dysfunction and Diabetic Cardiomyopathy.
    Wang M; Li Y; Li S; Lv J
    Front Endocrinol (Lausanne); 2022; 13():851941. PubMed ID: 35464057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell.
    Khan S; Ahmad SS; Kamal MA
    Endocr Metab Immune Disord Drug Targets; 2021; 21(2):268-281. PubMed ID: 32735531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetic cardiomyopathy].
    Huang YQ; Wang X; Kong W
    Sheng Li Ke Xue Jin Zhan; 2010 Feb; 41(1):31-6. PubMed ID: 21417012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy.
    Evangelista I; Nuti R; Picchioni T; Dotta F; Palazzuoli A
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic cardiomyopathy--fact or fiction?
    Maisch B; Alter P; Pankuweit S
    Herz; 2011 Mar; 36(2):102-15. PubMed ID: 21424347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic cardiomyopathy: where we are and where we are going.
    Lee WS; Kim J
    Korean J Intern Med; 2017 May; 32(3):404-421. PubMed ID: 28415836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus.
    Nakamura K; Miyoshi T; Yoshida M; Akagi S; Saito Y; Ejiri K; Matsuo N; Ichikawa K; Iwasaki K; Naito T; Namba Y; Yoshida M; Sugiyama H; Ito H
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy.
    Cheng Y; Wang Y; Yin R; Xu Y; Zhang L; Zhang Y; Yang L; Zhao D
    Front Endocrinol (Lausanne); 2023; 14():1162754. PubMed ID: 37065745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptozotocin-induced type II diabetic rat administered with nonobesogenic high-fat diet is highly susceptible to myocardial ischemia-reperfusion injury: An insight into the function of mitochondria.
    Ansari M; Gopalakrishnan S; Kurian GA
    J Cell Physiol; 2019 Apr; 234(4):4104-4114. PubMed ID: 30191974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of hyperglycaemia in the development of diabetic cardiomyopathy.
    El Hayek MS; Ernande L; Benitah JP; Gomez AM; Pereira L
    Arch Cardiovasc Dis; 2021 Nov; 114(11):748-760. PubMed ID: 34627704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Overview of Diabetic Cardiomyopathy.
    Quaiyoom A; Kumar R
    Curr Diabetes Rev; 2024; 20(5):e121023222139. PubMed ID: 37842898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvianolic acid B improves myocardial function in diabetic cardiomyopathy by suppressing IGFBP3.
    Li CL; Liu B; Wang ZY; Xie F; Qiao W; Cheng J; Kuang JY; Wang Y; Zhang MX; Liu DS
    J Mol Cell Cardiol; 2020 Feb; 139():98-112. PubMed ID: 31982427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic cardiomyopathy: role of the E3 ubiquitin ligase.
    Bai T; Wang F; Mellen N; Zheng Y; Cai L
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E473-83. PubMed ID: 26732687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory Serine Proteases Play a Critical Role in the Early Pathogenesis of Diabetic Cardiomyopathy.
    Kolpakov MA; Sikder K; Sarkar A; Chaki S; Shukla SK; Guo X; Qi Z; Barbery C; Sabri A; Rafiq K
    Cell Physiol Biochem; 2019; 53(6):982-998. PubMed ID: 31829530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants.
    Prandi FR; Evangelista I; Sergi D; Palazzuoli A; Romeo F
    Heart Fail Rev; 2023 May; 28(3):597-606. PubMed ID: 35001338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease.
    Jia G; Whaley-Connell A; Sowers JR
    Diabetologia; 2018 Jan; 61(1):21-28. PubMed ID: 28776083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis, Clinical Features and Treatment of Diabetic Cardiomyopathy.
    Alonso N; Moliner P; Mauricio D
    Adv Exp Med Biol; 2018; 1067():197-217. PubMed ID: 28980272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The limited clinical value of a specific diabetic cardiomyopathy.
    Vigili de Kreutzenberg S; Avogaro A
    Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):599-605. PubMed ID: 23725770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of caveolin as a target in the prevention and treatment of diabetic cardiomyopathy.
    Xia W; Li X; Wu Q; Xu A; Zhang L; Xia Z
    Front Immunol; 2022; 13():951381. PubMed ID: 36405687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.